Literature DB >> 9706361

Neuropsychological, physical, and psychosocial functioning of individuals with end-stage renal disease.

B A Bremer1, K M Wert, A L Durica, A Weaver.   

Abstract

Individuals (N = 24) being treated for end-stage renal disease (ESRD) were compared to healthy control participants (N = 20) on measures of neuropsychological, physical, and psychosocial functioning. ESRD patients scored significantly lower than controls (p < .03) on Trail Making Test--Part B; 37.5% of ESRD patients were classified as impaired versus 15% of controls. ESRD patients scored lower than controls on SF-36 measures of Physical Functioning (p < .001). Psychosocial deficits were on the Affect Balance Scale (p < .04) and in employment (p < .04). The hypotheses that neuropsychological status would be associated with psychosocial differences in terms of decrements in both affect and employment rates were also supported. Mediational analysis suggested that neuropsychological status plays a role in the lower employment rates seen among ESRD patients. Clinical and research implications are discussed.

Entities:  

Mesh:

Year:  1997        PMID: 9706361     DOI: 10.1007/BF02895153

Source DB:  PubMed          Journal:  Ann Behav Med        ISSN: 0883-6612


  10 in total

1.  The kidney disease quality of life cognitive function subscale and cognitive performance in maintenance hemodialysis patients.

Authors:  Eric P Sorensen; Mark J Sarnak; Hocine Tighiouart; Tammy Scott; Lena M Giang; Bethany Kirkpatrick; Kristina Lou; Daniel E Weiner
Journal:  Am J Kidney Dis       Date:  2012-03-15       Impact factor: 8.860

2.  Cognitive function and dialysis adequacy: no clear relationship.

Authors:  Lena M Giang; Daniel E Weiner; Brian T Agganis; Tammy Scott; Eric P Sorensen; Hocine Tighiouart; Mark J Sarnak
Journal:  Am J Nephrol       Date:  2010-10-21       Impact factor: 3.754

3.  Subclinical Cognitive Impairment and Listing for Kidney Transplantation.

Authors:  Aditi Gupta; Robert N Montgomery; Victor Bedros; John Lesko; Jonathan D Mahnken; Shweta Chakraborty; David Drew; Jeffrey A Klein; Tashra S Thomas; Amna Ilahe; Pooja Budhiraja; William M Brooks; Timothy M Schmitt; Mark J Sarnak; Jeffrey M Burns; Diane M Cibrik
Journal:  Clin J Am Soc Nephrol       Date:  2019-03-19       Impact factor: 10.614

4.  Structural and functional brain alterations in end stage renal disease patients on routine hemodialysis: a voxel-based morphometry and resting state functional connectivity study.

Authors:  Yingwei Qiu; Xiaofei Lv; Huanhuan Su; Guihua Jiang; Cheng Li; Junzhang Tian
Journal:  PLoS One       Date:  2014-05-22       Impact factor: 3.240

Review 5.  Cognitive Impairment in Chronic Kidney Disease: Vascular Milieu and the Potential Therapeutic Role of Exercise.

Authors:  Ulf G Bronas; Houry Puzantian; Mary Hannan
Journal:  Biomed Res Int       Date:  2017-04-19       Impact factor: 3.411

6.  Prevalence and correlates of cognitive impairment in kidney transplant recipients.

Authors:  Aditi Gupta; Jonathan D Mahnken; David K Johnson; Tashra S Thomas; Dipti Subramaniam; Tyler Polshak; Imran Gani; G John Chen; Jeffrey M Burns; Mark J Sarnak
Journal:  BMC Nephrol       Date:  2017-05-12       Impact factor: 2.388

7.  Structural and Functional Brain Changes in Hemodialysis Patients with End-Stage Renal Disease: DTI Analysis Results and ALFF Analysis Results.

Authors:  Huiying Guo; Wenjin Liu; Haige Li; Junwei Yang
Journal:  Int J Nephrol Renovasc Dis       Date:  2021-03-09

8.  Nocturnal sleep, daytime sleepiness, and quality of life in stable patients on hemodialysis.

Authors:  Kathy P Parker; Nancy G Kutner; Donald L Bliwise; James L Bailey; David B Rye
Journal:  Health Qual Life Outcomes       Date:  2003-11-21       Impact factor: 3.186

9.  Mild-moderate CKD is not associated with cognitive impairment in older adults in the Alzheimer's Disease Neuroimaging Initiative cohort.

Authors:  Aditi Gupta; Kevin Kennedy; Jaime Perales-Puchalt; David Drew; Srinivasan Beddhu; Mark Sarnak; Jeffrey Burns
Journal:  PLoS One       Date:  2020-10-09       Impact factor: 3.752

10.  Mild to moderate decrease in eGFR and cognitive decline in older adults.

Authors:  Michael Grasing; Kevin Kennedy; Mark J Sarnak; Jeffrey M Burns; Aditi Gupta
Journal:  Nephrol Dial Transplant       Date:  2022-07-26       Impact factor: 7.186

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.